This inventor holds 56 USPTO granted patents and 18 published patent applications, plus 6 CIPO patents and 33 EPO patents, primarily in Biochemical Inhibitors (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., Merck Sharp + Dohme Corp., European Molecular Biology Laboratory. Active years: 2006-2025.
Inventors with similar research interests:
Location History:
- Nutley, NJ (US) (2006 - 2016)
- Verona, NJ (US) (2012 - 2021)
Company Filing History:
38 out of 5,020 
10 out of 2,405 
6 out of 79 
Years Active: 2006-2025
Areas of Expertise:
Title: Innovations and Contributions of Sung-Sau So in Pharmaceutical Patents
Introduction
Sung-Sau So is a prominent inventor based in Verona, NJ, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 53 patents, he has dedicated his work to developing innovative solutions for various medical conditions.
Latest Patents
Among Sung-Sau So's latest innovations are two notable patents. The first is focused on arginase inhibitors and methods of use, which describes compounds of Formula I or a pharmaceutically acceptable salt thereof. These compounds serve as arginase inhibitors, offering potential in the prevention, treatment, and remediation of arginase-related diseases. The second patent involves inhibitors of Bruton's tyrosine kinase, detailing compounds that modulate Btk activity. These compounds are crucial in treating oncological, autoimmune, and inflammatory diseases associated with aberrant B-cell activation. Both patents not only represent significant advancements in medical science but also highlight his commitment to addressing complex health challenges.
Career Highlights
Throughout his career, Sung-Sau So has collaborated with prestigious companies, including Hoffmann-La Roche Inc. and Merck Sharp & Dohme Corporation. His work in these organizations has allowed him to explore new horizons in drug development and patent creation, ultimately benefitting the healthcare sector.
Collaborations
In his professional journey, Sung-Sau So has had the privilege of working alongside distinguished colleagues such as Fariborz Firooznia and Tai-An Lin. These collaborations have not only fostered innovative ideas but also contributed to his success as a leading inventor in pharmaceuticals.
Conclusion
Sung-Sau So's extensive patent portfolio and his work within notable pharmaceutical companies underscore his role as a trailblazer in drug development. His contributions, particularly in the areas of arginase inhibitors and Bruton's tyrosine kinase, embody the spirit of innovation necessary for addressing critical health issues. As the landscape of pharmaceuticals continues to evolve, Sung-Sau So remains at the forefront, driving advancements that stand to benefit countless individuals globally.